M. Pourgholami

发表

Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways.

F. Bahrami, Ahmed H. Mekkawy, S. Badar, 2021, American journal of cancer research.

HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor

Ahmed H. Mekkawy, D. Morris, M. Pourgholami, 2012, Journal of oncology.

Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit[n]uril.

J. Collins, D. Morris, M. Pourgholami, 2008, Organic & biomolecular chemistry.

Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril.

J. Collins, D. Morris, M. Pourgholami, 2010, Organic & biomolecular chemistry.

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

Roger Liang, Martina Stenzel, D. Morris, 2015, Journal of Nanobiotechnology.

Effect of shell-crosslinking of micelles on endocytosis and exocytosis: acceleration of exocytosis by crosslinking.

D. Morris, M. Pourgholami, Hongxu Lu, 2013, Biomaterials science.

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Alireza Khoshnevisan, Thomas Efferth, Daniele Focosi, 2013, Oncotarget.

In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole.

D. Morris, M. Pourgholami, D L Morris, 2001, Cancer letters.

Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study.

D. Morris, M. Pourgholami, M. Stenzel, 2012, Biomacromolecules.

Minocycline inhibits growth of epithelial ovarian cancer.

Ahmed H. Mekkawy, S. Badar, D. Morris, 2012, Gynecologic oncology.

The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.

D. Morris, M. Pourgholami, S. Chu, 2010, Anticancer research.

Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.

D. Morris, M. Pourgholami, Kiran T Wangoo, 2008, Anticancer research.

Albendazole : a Potent Inhibitor of Vascular Endothelial Growth Factor andMalignant Ascites Formation in OVCAR-3 Tumor-Bearing

M. Pourgholami, Z. Cai, LisaWang Ying Lu, 2006 .

Tumor-Bearing Nude Mice OVCAR-3 Growth Factor and Malignant Ascites Formation in Albendazole : a Potent Inhibitor of Vascular Endothelial

M. Pourgholami, Z. Cai, Ying Lu, 2006 .

Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis

Lisa I. Wang, D. Morris, M. Pourgholami, 2005, Cancer Chemotherapy and Pharmacology.

Methode de traitement de cancers et compositions appropriees

M. Pourgholami, D. L. Morris, 2002 .

In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.

D. Morris, M. Pourgholami, Y. Lu, 2000, Cancer letters.

Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma

T. Chua, D. Morris, M. Pourgholami, 2015, American journal of clinical oncology.

Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma

T. Chua, D. Morris, M. Pourgholami, 2013, Journal of Cancer Research and Clinical Oncology.

Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod

L. Dargahi, M. Pourgholami, M. Javan, 2022, Frontiers in Pharmacology.

Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies

D. Morris, M. Pourgholami, P. Ataie-Kachoie, 2013, PloS one.

MUC1 as a Potential Target in Anticancer Therapies

T. Chua, D. Morris, M. Pourgholami, 2015, American journal of clinical oncology.

Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies.

S. Badar, D. Morris, M. Pourgholami, 2015, American journal of cancer research.

Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway.

F. Bahrami, Ahmed H. Mekkawy, D. Morris, 2014, American journal of cancer research.

Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer.

F. Bahrami, D. Morris, M. Pourgholami, 2014, American journal of cancer research.

Original Article Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer

F. Bahrami, D. Morris, M. Pourgholami, 2014 .

Original Article Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma

T. Chua, D. Morris, M. Pourgholami, 2013 .

Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?

T. Chua, D. Morris, M. Pourgholami, 2013, American journal of cancer research.

Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways.

S. Badar, D. Morris, M. Pourgholami, 2013, Gynecologic oncology.

Diffuse malignant peritoneal mesothelioma--an update on treatment.

T. Chua, D. Morris, M. Pourgholami, 2012, Cancer treatment reviews.

1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies

D. Morris, M. Pourgholami, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

1,25-Dihydroxyvitamin D3 induced cell cycle arrest in the human primary liver cancer cell line HepG2

D. Morris, M. Pourgholami, J. Akhter, 2003 .

1α,25‐Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2

I. Finlay, D. Morris, M. Pourgholami, 2001, ANZ journal of surgery.

In vitro and in vivo inhibition of liver cancer cells by 1 , 25-dihydroxyvitamin D 3

D. Morris, M. Pourgholami, Y. Lu, 2000 .

Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice

M. Pourgholami, M. Javan, J. Mirnajafi-zadeh, 2014, Neurological Sciences.

Tetracyclines: drugs with huge therapeutic potential.

F. Bahrami, D. Morris, M. Pourgholami, 2012, Mini reviews in medicinal chemistry.

Intra-amygdala infusion of 2-chloroadenosine suppresses amygdala-kindled seizures

M. Pourgholami, J. Mirnajafi-zadeh, M. Palizvan, 1997, Brain Research.

Estrogen as a key regulator of energy homeostasis and metabolic health.

F. Tehrani, L. Dargahi, M. Pourgholami, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Neuroprotective effects of astaxanthin in a rat model of spinal cord injury

L. Dargahi, M. Pourgholami, M. Manoochehri, 2017, Behavioural Brain Research.

Triggering the fast release of drugs from crosslinked micelles in an acidic environment

D. Morris, M. Pourgholami, M. Stenzel, 2011 .

Crosslinked micelles as an avenue to smart coreshell nanoparticles for drug delivery

D. Morris, M. Pourgholami, M. Stenzel, 2011 .

Estradiol alters afterdischarge threshold and acquisition of amygdala kindled seizures in male rats

M. Pourgholami, M. Saberi, 2003, Neuroscience Letters.

Effects of chronic estradiol benzoate treatment on amygdala kindled seizures in male rats

M. Pourgholami, M. Saberi, M. Jorjani, 2001, Epilepsy Research.

The acute effects of estradiol benzoate on amygdala-kindled seizures in male rats

M. Pourgholami, M. Saberi, M. Jorjani, 2001, Brain Research.

Comparison of Shell-Cross-Linked Micelles with Soft and Glassy Cores as a Drug Delivery Vehicle for Albendazole: Is There a Difference in Performance?

D. Morris, M. Pourgholami, M. Stenzel, 2012 .

An optimized RGD-decorated micellar drug delivery system for albendazole for the treatment of ovarian cancer: from RAFT polymer synthesis to cellular uptake.

D. Morris, M. Pourgholami, M. Stenzel, 2011, Macromolecular bioscience.

Inhibitors of vascular endothelial growth factor in cancer.

D. Morris, M. Pourgholami, 2008, Cardiovascular & hematological agents in medicinal chemistry.

Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol.

Lisa I. Wang, D. Morris, M. Pourgholami, 2004, Cancer letters.

Synthesis of semi-biodegradable crosslinked microspheres for the delivery of 1,25 dihydroxyvitamin D3 for the treatment of hepatocellular carcinoma

C. Barner‐Kowollik, D. Morris, M. Pourgholami, 2007 .

Urokinase plasminogen activator system as a potential target for cancer therapy.

Ahmed H. Mekkawy, D. Morris, M. Pourgholami, 2009, Future oncology.

Gene of the month: Interleukin 6 (IL-6)

D. Richardson, D. Morris, M. Pourgholami, 2014, Journal of Clinical Pathology.

Human Sprouty1 suppresses growth, migration, and invasion in human breast cancer cells

Ahmed H. Mekkawy, D. Morris, M. Pourgholami, 2014, Tumor Biology.

Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration.

D. Morris, M. Pourgholami, P. Galettis, 2007, Anticancer research.

Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.

D. Morris, M. Pourgholami, J. Akhter, 2008, Anticancer research.

The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review study

M. Pourgholami, S. Fakhri, M. Jorjani, 2019, Nutrition and cancer.

MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma

T. Chua, D. Morris, M. Pourgholami, 2013, The International journal of biological markers.

Involvement of Urokinase‐Type Plasminogen Activator System in Cancer: An Overview

Ahmed H. Mekkawy, D. Morris, M. Pourgholami, 2014, Medicinal research reviews.

Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model

A. Perkins, Yong Li, J. Kearsley, 2011, PloS one.

Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer.

K. Patterson, A. Perkins, Yong Li, 2011, Cancer letters.

Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.

D. Morris, M. Pourgholami, Kiran T Wangoo, 2007, Biochemical pharmacology.

PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery.

D. Morris, M. Pourgholami, Hongxu Lu, 2016, Biomacromolecules.

Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines

D. Morris, M. Pourgholami, A. Amini, 2012, Journal of oncology.

Diagnostic Accuracy of Ultrasound in Determining the Cause of Bilious Vomiting in Neonates

P. Salamati, M. Pourgholami, M. Naseri, 2012, Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society.

Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer.

D. Morris, M. Pourgholami, P. Ataie-Kachoie, 2013, Cytokine & growth factor reviews.

p70 Ribosomal protein S6 kinase (Rps6kb1): an update

D. Morris, M. Pourgholami, P. Ataie-Kachoie, 2014, Journal of Clinical Pathology.

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

D. Morris, M. Pourgholami, A. Amini, 2011, Cancer and Metastasis Reviews.

Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole.

S. Badar, D. Morris, M. Pourgholami, 2009, Anticancer research.

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

M. Links, D. Morris, M. Pourgholami, 2010, Cancer Chemotherapy and Pharmacology.

Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

T. Chua, D. Morris, M. Pourgholami, 2013, American journal of cancer research.

Ki 67-BCL 2 index in prognosis of malignant peritoneal mesothelioma

T. Chua, D. Morris, M. Pourgholami, 2013 .

Novel protein interactors of urokinase-type plasminogen activator receptor.

Ahmed H. Mekkawy, D. Morris, M. Pourgholami, 2010, Biochemical and biophysical research communications.

The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF.

M. Pourgholami, M. Z. I. Pranjol, J. Yuzugulen, 2023, European journal of pharmacology.

Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer

S. Badar, D. Morris, M. Pourgholami, 2013, Molecular Cancer Research.

Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics

L. Dargahi, M. Pourgholami, N. Izadi, 2020, Pituitary.

Inhibition of Cell Proliferation, Vascular Endothelial Growth Factor and Tumor Growth by Albendazole

M. Links, S. Badar, D. Morris, 2009, Cancer investigation.

Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole

M. Poruchynsky, S. Badar, D. Morris, 2010, BMC Cancer.

Optimizing radioimmunoconjugate delivery in the treatment of solid tumor.

M. Pourgholami, B. Allen, Chen-Yu Huang, 2012, Cancer treatment reviews.

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

D. Morris, M. Pourgholami, A. Amini, 2011, Cancer and Metastasis Reviews.

Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

D. Morris, M. Pourgholami, A. Amini, 2011, Journal of oncology.

The critical role of vascular endothelial growth factor in tumor angiogenesis.

D. Morris, M. Pourgholami, A. Amini, 2012, Current cancer drug targets.

Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy

D. Morris, M. Pourgholami, Bhavneet Singh, 2018, AntiCancer Research.

Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma.

T. Gruenberger, I. Finlay, D. Morris, 2002, International journal of oncology.

Chronic Extrahepatic Bile Duct Dilatation: Sonographic Screening in the Patients with Opioid Addiction

M. Pourgholami, H. Farahmand, M. Fathollah, 2007, Korean journal of radiology.

Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats

M. Pourgholami, Ahmadiani Abolhassan, Sayyah Mohammad, 1998, Epilepsy Research.

Intraperitoneal and intraamygdala N 6-cyclohexyladenosine suppress hippocampal kindled seizures in rats

M. Pourgholami, Y. Fathollahi, J. Mirnajafi-zadeh, 2000, Brain Research.

Albendazole loaded albumin nanoparticles for ovarian cancer therapy

D. Morris, M. Pourgholami, Mingtao Liang, 2014 .

The role of ERα36 in cell type-specific functions of estrogen and cancer development.

F. Ramezani Tehrani, L. Dargahi, M. Pourgholami, 2020, Pharmacological research.

Synthetic miR-21 decoy circularized by tRNA splicing mechanism inhibited tumorigenesis in glioblastoma in vitro and in vivo models

S. Mowla, M. Pourgholami, Hadi Bayat, 2023, Molecular therapy. Nucleic acids.

1,25-Dihydroxyvitamin D(3) induced cell cycle arrest in the human primary liver cancer cell line HepG2.

D. Morris, M. Pourgholami, J. Akhter, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.

Lisa Wang, Levon M Khachigian, L. Khachigian, 2010, Biochemical and biophysical research communications.

Pilot Study of Albendazole in Patients with Advanced Malignancy

D. Morris, M. Pourgholami, J. Jourdan, 2001, Oncology.

Albendazole inhibits paclitaxel-resistant 1A9PTX22 ovarian cancer cells.

D. Morris, M. Pourgholami, Ying Lu, 2006 .

Anticonvulsant action of 2-chloroadenosine injected focally into the perirhinal cortex in amygdaloid kindled rats

M. Pourgholami, J. Mirnajafi-zadeh, M. Palizvan, 1999, Epilepsy Research.

BUPROPION-INDUCE D CLIMBING THROU GH D -1 AND D-2 DOPAMINE RECEPTOR ACTIVATION

M. Zarrindast, M. Pourgholami, Yadollah KHAlENABI, 1993 .

Concordance between digital pathology and light microscopy in general surgical pathology: a pilot study of 100 cases

Joseph P Houghton, Peter W Hamilton, N. Sebire, 2014, Journal of Clinical Pathology.

Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer

S. Badar, D. Morris, M. Pourgholami, 2013, Molecular Cancer Research.

Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril.

M. Pourgholami, Yunjie Zhao, Anthony I Day, 2010, Organic & biomolecular chemistry.

CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme

M. Pourgholami, B. Soltani, S. Shafiee, 2024, BMC cancer.

THE ROLE OF SONOGRAPHY IN DIAGNOSIS OF THE INTERNAL ABDOMINAL INJURIES DUE TO TRAUMA

M. Pourgholami, M. Rezaeinasab, H. Farahmand, 2007 .

Peritoneal mesothelioma in a woman who has survived for seven years: a case report

D. Morris, M. Pourgholami, K. Pillai, 2011, Journal of medical case reports.

PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery.

D. Morris, M. Pourgholami, Hongxu Lu, 2016, Biomacromolecules.

Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model

M. Pourgholami, J. Mirnajafi-zadeh, S. Pournajaf, 2024, BMC cancer.